| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药及医疗器材(元) | 11,501,017.14 | 19,654,565.68 | 12,815,751.35 | 28,248,595.30 | 22,981,461.44 |
| 医药制造业(元) | 10,189,278.61 | 37,390,066.62 | 21,575,888.00 | 23,355,385.43 | 14,853,822.33 |
| 专业技术服务(元) | 1,196,113.33 | 5,519,259.71 | 2,770,783.76 | 9,471,698.20 | 1,698,113.21 |
| 电缆通讯设备(元) | - | 7,831,304.00 | - | 7,346,315.97 | - |
| 化学原料试剂(元) | - | 8,371,730.37 | - | 3,433,331.60 | - |
| 营业成本(元) | |||||
| 医药及医疗器材(元) | 8,203,698.40 | 6,316,542.52 | 7,545,587.30 | 10,850,017.65 | 10,933,486.24 |
| 医药制造业(元) | 5,932,618.27 | 10,054,628.08 | 5,180,283.61 | 10,318,716.54 | 5,653,303.63 |
| 专业技术服务(元) | 77,361.89 | 506,328.58 | 175,525.63 | 528,066.65 | 197,234.32 |
| 电缆通讯设备(元) | - | 6,298,768.20 | - | 4,407,498.21 | - |
| 化学原料试剂(元) | - | 6,872,384.92 | - | 2,638,875.95 | - |
| 毛利(元) | |||||
| 医药及医疗器材(元) | 3,297,318.74 | 13,338,023.16 | 5,270,164.05 | 17,398,577.65 | 12,047,975.20 |
| 医药制造业(元) | 4,256,660.34 | 27,335,438.54 | 16,395,604.39 | 13,036,668.89 | 9,200,518.70 |
| 专业技术服务(元) | 1,118,751.44 | 5,012,931.13 | 2,595,258.13 | 8,943,631.55 | 1,500,878.89 |
| 电缆通讯设备(元) | - | 1,532,535.80 | - | 2,938,817.76 | - |
| 化学原料试剂(元) | - | 1,499,345.45 | - | 794,455.65 | - |
| 毛利率(%) | |||||
| 医药及医疗器材(%) | 28.67 | 67.86 | 41.12 | 61.59 | 52.42 |
| 医药制造业(%) | 41.78 | 73.11 | 75.99 | 55.82 | 61.94 |
| 专业技术服务(%) | 93.53 | 90.83 | 93.67 | 94.42 | 88.39 |
| 电缆通讯设备(%) | - | 19.57 | - | 40.00 | - |
| 化学原料试剂(%) | - | 17.91 | - | 23.14 | - |
| 收入构成(%) | |||||
| 医药及医疗器材(%) | 50.25 | 24.95 | 34.49 | 39.31 | 58.13 |
| 医药制造业(%) | 44.52 | 47.47 | 58.06 | 32.50 | 37.57 |
| 专业技术服务(%) | 5.23 | 7.01 | 7.46 | 13.18 | 4.30 |
| 电缆通讯设备(%) | - | 9.94 | - | 10.22 | - |
| 化学原料试剂(%) | - | 10.63 | - | 4.78 | - |
| 毛利构成(%) | |||||
| 医药及医疗器材(%) | 38.02 | 27.38 | 21.72 | 40.36 | 52.96 |
| 医药制造业(%) | 49.08 | 56.11 | 67.58 | 30.24 | 40.44 |
| 专业技术服务(%) | 12.90 | 10.29 | 10.70 | 20.75 | 6.60 |
| 电缆通讯设备(%) | - | 3.15 | - | 6.82 | - |
| 化学原料试剂(%) | - | 3.08 | - | 1.84 | - |